SCHEMBL6062893

SCHEMBL6062893

CC(C)(C)OC(=O)N[C@@H](CS(=O)(=O)Cc1ccccc1)C(=O)N(CCCc1ccccc1)[C@@H](O)c1nccs1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 4/20 0.38
CTSK P43235 4/20 0.38
CTSS P25774 3/20 0.38
MAPT P10636 1/20 0.38
ATM Q13315 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6627818 0.84 SYK (0.36) PTPRBCTSKCTSSMAPTATM
SCHEMBL6628049 0.80 CTSK (0.44) PTPRBCTSKCTSSMAPTATM
SCHEMBL6628047 0.80 CTSK (0.44) PTPRBCTSKCTSSMAPTATM
SCHEMBL6628052 0.80 CTSK (0.44) PTPRBCTSKCTSSMAPTATM
SCHEMBL6702656 0.80 CTSK (0.44) PTPRBCTSKCTSSMAPTATM
SCHEMBL6631485 0.79 HDAC3 (0.41) PTPRBCTSKMAPTATM
SCHEMBL6628447 0.75 MAPT (0.42) CTSKMAPTATMMEN1ALDH1A1
SCHEMBL6061710 0.75 MAPT (0.42) CTSKMAPTATMMEN1ALDH1A1
SCHEMBL6630571 0.73 PPARA (0.57) CTSKCTSSMAPTATMMEN1
SCHEMBL6630572 0.73 PPARA (0.57) CTSKCTSSMAPTATMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP claimed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP disclosed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed